⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
•🌟SS-31 for research use only:
Welcome to the authoritative reference category for the SS-31 peptide matrix. This premium compound architecture integrates advanced cellular bioenergetics increments into a single co-lyophilized reference standard, offering high structural longevity for in-vitro evaluation layouts. By anchoring these specialized chains together at a standardized distribution ratio, laboratories can significantly streamline operational workflows and observe complex metabolic cascades without managing manual ratio variations between individual testing runs.
•🔮1. Coordinated Component Architecture
| Sequence Configuration: | A specialized 4-amino acid linear structure optimized for organelle localization modeling in laboratory settings. |
| Mitochondrial Base: | Synthetic formulation engineered to specifically target and interact with cardiolipin within inner membrane systems. |
| Residue Modification: | Incorporates a specialized 2',6'-dimethyltyrosine modification to support prolonged stability thresholds in test media. |
•🧬2. Synergistic Material Overview
Instead of purchasing and measuring multiple individual sequence standards, investigators choose this integrated reference tool because it removes concentration variance during fluid preparation. High-yield automated peptide chemistry secures unvarying compound distribution across each unique reference batch. Preclinical models evaluate the operation of these active chains to monitor cell signaling responses, receptor feedback loops, and comparative bioenergetic thresholds cleanly. Fast domestic shipping lanes manage transport quickly to maintain core structural parameters from laboratory dispatch straight to assay setups.
•🧪3. Advanced Research & Preclinical FAQ
•🛡️What accounts for the primary structural characteristics of the SS-31 reference standard?
Preclinical literature monitors this layout as a reference preparation incorporating highly pure incremental structures like elamipretide sequences. The alternating aromatic-cationic peptide backbone is evaluated for its specific cell permeability and binding affinity thresholds.
•🛡️Why does the molecular weight data remain consistent across different reference batches?
The primary published molecular formula reflects the standardized sequence in the presentation, though each lot maintains its distinct identity verified by high-resolution mass spectrometry to ensure no trace modifications or peptide cleavage anomalies exist.
•🛡️What analytical methods ensure structural trace confirmation across categories?
Laboratories utilize reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (ESI-MS) to quantify individual peak retentions, trace verification parameters, and confirm lot uniformity.
•🛡️What handling and storage protocols secure long-term molecular parameter tracking?
Store dry powder cake sealed at -20°C to guard against humidity and premature breakdown. Following reconstitution with proper sterile solvents or bacteriostatic water under clean laboratory procedures, preserve remaining fluid samples at 2-8°C, and complete planned tracking assays within the certified testing window.
•📊4. Consolidated Reference Specifications
| Technical Architecture: | Cell-Permeable Aromatic-Cationic Tetrapeptide Reference Preparation |
| Molecular Formula Base: | C32H49N9O5 (Average Mass Approximately 639.80 g/mol) |
| Purity Threshold: | At least 98 - 99 percent as determined by reversed-phase HPLC (RP-HPLC) |
| Reference Traceability Code: | CAS Identifier 73813-92-0 / 736992-21-5 (For Lot Traceability Logs) |
| Solubility Threshold: | Soluble in Water and Sterile Bacteriostatic Fluids |
•📚Preclinical & Scientific References
For verification of the biological mechanisms, amino acid modifications, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Szeto, H. H., et al. (2005). Intentional cell-permeable aromatic-cationic peptide alternatives target mitochondrial cardiolipin configurations in vitro. Journal of Biological Chemistry, 280(31), 28453-28461.
- • Birk, A. V., et al. (2014). Role of the dimethyltyrosine residue in structural peptide stability metrics and inner membrane affinity profiles. The AAPS Journal, 16(4), 722-730.
- • Zhao, K., et al. (2005). Evaluation of MTP-131 sequence alignments and complex bioenergetic localization thresholds inside laboratory assay layouts. European Journal of Pharmacology, 512(2), 109-117.
- • Muller, F. L., et al. (2007). Cellular bioenergetics feedback cascades and metabolic pathway analysis of linear incretin-class and aromatic tetrapeptides. Biochemical Journal, 403(3), 491-500.
99% Purity Guaranteed
Independent Lab Tested
